$BLLN

Atay Oguzhan sold $2.3M of BLLN

Atay Oguzhan (Chairman and CEO) sold 15,539 shares of BillionToOne, Inc. (BLLN) at $150.03 ($2.33M total) on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Atay Oguzhan
Published Aug 7, 2026, 8:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale amount, date, and that it was executed under a pre-arranged Rule 10b5-1 plan; no other company-specific catalyst is provided.

02

Market read

Traders may note insider selling, but the 10b5-1 framing reduces the likelihood of a fundamental signal.

03

What to watch

The article provides only the sale details; it does not include any concurrent buy transactions, lockups, or changes in company fundamentals that would better explain trading impact.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-07, transaction dated 2026-08-05

Background

The article is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc. (BLLN).

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

BillionToOne Form 4 shows CEO/Chairman Atay Oguzhan sold 15,539 shares on 2026-08-05 under a 10b5-1 plan for about $2.33M.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicitly stated 10b5-1 pre-arranged plan and no accompanying company guidance, deal, or regulatory event in the text.

Market effects

No sector-level implications disclosed; this is company-specific insider trading reporting.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan and the CEO still holds no shares after the sale, the market may overreact to a non-informational transaction.

Key entities

  • BillionToOne, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Atay Oguzhan

    Chairman and CEO who sold 15,539 shares under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.